NDC 59651-055 – Teriflunomide
Teriflunomide 14 mg/1 · Tablet · Oral
Product NDC59651-055
Product details
- Brand name
- Teriflunomide
- Generic name
- Teriflunomide
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA209638
- Marketed since
- February 28, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Pyrimidine Synthesis Inhibitor
Active ingredients
- Teriflunomide 14 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 59651-055-28 | 2 BLISTER PACK in 1 CARTON (59651-055-28) / 14 TABLET in 1 BLISTER PACK | Feb 28, 2023 |
| 59651-055-30 | 30 TABLET in 1 BOTTLE (59651-055-30) | Feb 28, 2023 |
Other Teriflunomide products
- 59651-054 Teriflunomide 7 mg/1 · Tablet · Aurobindo Pharma Limited
- 69339-170 Teriflunomide 14 mg/1 · Tablet · Natco Pharma USA LLC
- 69339-169 Teriflunomide 7 mg/1 · Tablet · Natco Pharma USA LLC
- 16729-399 Teriflunomide 7 mg/1 · Tablet, Film Coated · Accord Healthcare Inc.
- 16729-400 Teriflunomide 14 mg/1 · Tablet, Film Coated · Accord Healthcare Inc.
- 62332-314 Teriflunomide 14 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-313 Teriflunomide 7 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 46708-313 Teriflunomide 7 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-314 Teriflunomide 14 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 42291-830 Teriflunomide 7 mg/1 · Tablet, Film Coated · AvKARE
- 42291-831 Teriflunomide 14 mg/1 · Tablet, Film Coated · AvKARE
- 70377-017 Teriflunomide 7 mg/1 · Tablet, Film Coated · Biocon Pharma Inc.